Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
VRCA on Nasdaq
Shares outstanding
16,075,855
Price per share
$8.30
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,468,945
Total reported value
$10,583,119
% of total 13F portfolios
0%
Share change
+2,274,817
Value change
+$10,479,755
Number of holders
31
Price from insider filings
$8.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Manning Paul B 50% $28,437,789 8,056,031 Paul B Manning 25 Nov 2025
Caligan Partners LP 10% 0% $43,635,492 6,503,054 0% Caligan Partners LP 26 Dec 2025
Affinity Asset Advisors, LLC 5.5% +0.6% $7,346,762 884,172 0% Affinity Asset Advisors, LLC 22 Jan 2026
ARMISTICE CAPITAL, LLC 6.8% $2,754,858 639,193 Armistice Capital, LLC 30 Sep 2025

As of 30 Sep 2025, 31 institutional investors reported holding 2,468,945 shares of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA). This represents 15% of the company’s total 16,075,855 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Caligan Partners LP 5.7% 923,910 0.55% $3,982,052
ARMISTICE CAPITAL, LLC 4% 639,193 0.09% $2,754,922
BOOTHBAY FUND MANAGEMENT, LLC 1.7% 280,734 0.03% $1,209,964
VANGUARD GROUP INC 1.4% 225,210 0% $970,655
Sovran Advisors, LLC 0.46% 73,805 0.02% $260,532
MILLENNIUM MANAGEMENT LLC 0.45% 71,990 0% $310,277
GEODE CAPITAL MANAGEMENT, LLC 0.42% 67,659 0% $291,687
UBS Group AG 0.26% 41,632 0% $179,434
RENAISSANCE TECHNOLOGIES LLC 0.18% 29,191 0% $125,813
Mariner, LLC 0.15% 24,550 0% $105,811
MORGAN STANLEY 0.13% 21,688 0% $93,475
STATE STREET CORP 0.13% 20,581 0% $88,704
NORTHERN TRUST CORP 0.12% 20,031 0% $86,334
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.07% 12,000 0% $51,720
BlackRock, Inc. 0.04% 6,148 0% $26,498
FMR LLC 0.02% 3,337 0% $14,382
CITIGROUP INC 0.01% 2,065 0% $8,900
Tower Research Capital LLC (TRC) 0.01% 1,543 0% $6,650
Capital Analysts, LLC 0.01% 1,500 0% $6,000
ROYAL BANK OF CANADA 0.01% 1,202 0% $5,000
Salomon & Ludwin, LLC 0% 290 0% $1,354
New England Capital Financial Advisors LLC 0% 200 0% $862
NISA INVESTMENT ADVISORS, LLC 0% 142 0% $612
BNP PARIBAS FINANCIAL MARKETS 0% 124 0% 0% $534
PNC Financial Services Group, Inc. 0% 102 0% $439

Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,435,253 $20,213,699 +$14,037,110 $8.31 33
2025 Q3 2,468,945 $10,583,119 +$10,479,755 $4.31 31
2025 Q2 194,004 $102,830 +$102,830 $0.53 4